Chronic Rhinitis — ongoing nasal inflammation has identifiable causes.

Chronic rhinitis refers to persistent inflammation of the nasal mucosa producing congestion, rhinorrhea, sneezing, or itching. In clinical practice, symptoms present for roughly 12 weeks or more are considered chronic rather than acute. The term describes a pattern, not a single cause, and common contributors include allergic triggers, non‑allergic irritants, medication effects, and anatomic narrowing. Definitive classification requires history, focused examination, and selective testing.

Allergic rhinitis is driven by IgE‑mediated responses to specific allergens and often includes sneezing and itchy eyes. Non‑allergic rhinitis lacks an IgE trigger and is typically provoked by irritants, temperature changes, strong odors, or foods. Symptom timing, associated eye symptoms, and response to antihistamines help separate the two. When history is unclear, skin or serum allergy testing can clarify management.

Evaluation begins with a detailed symptom history, medication review, and focused anterior and endoscopic nasal examination. Nasal endoscopy inspects turbinates, septum, mucosa, and posterior drainage and helps distinguish mucosal swelling from fixed structural narrowing. Selective tests include skin or serum allergy testing and a sinus CT when sinus disease or anatomy may affect management. Olfactory testing or allergist referral is arranged when indicated by symptoms or exam findings.

Optimized medical therapy—saline irrigation, topical intranasal corticosteroids, targeted antihistamines, or intranasal anticholinergics—controls many patients. Procedures are considered when symptoms remain functionally limiting despite an adequate medical trial, when an anatomic contributor is identified, or when neural‑mediated rhinorrhea predominates. Choice of procedure depends on symptom pattern, objective findings, and patient goals. An in‑person assessment determines whether office intervention or formal surgery is appropriate.

Office options target mucosal tissue or parasympathetic neural input. Posterior nasal nerve–directed treatments, such as cryotherapy or controlled radiofrequency, aim to reduce rhinorrhea and some congestion symptoms. In‑office turbinate procedures—submucosal ablation or cautery—reduce bulk while attempting to preserve mucosal function. Device choice and candidacy are individualized after endoscopic assessment.

Turbinate reduction reduces bulky mucosa that narrows the airway and addresses reversible mucosal contributors. Septoplasty corrects a deviated septum producing fixed side‑to‑side obstruction. They address different mechanical problems and are often combined when both contribute to symptoms. Preservation techniques aim to improve airflow while maintaining mucociliary function.

Persistent mucosal inflammation can impair mucociliary clearance and obstruct sinus ostia, increasing the risk of recurrent or chronic sinusitis. Conversely, chronic sinus disease commonly amplifies nasal symptoms, so distinguishing the dominant process is important for treatment planning. Endoscopic assessment and sinus CT help determine whether isolated medical therapy or combined surgical treatment is needed. Coordination with sinus specialists yields better outcomes when both processes coexist.

Early recovery often includes congestion, crusting, and mild discomfort for several days to two weeks. Many patients notice airflow improvement within days to weeks; maximal benefit frequently appears over three to six months as swelling subsides. Potential complications include bleeding, infection, persistent obstruction, altered nasal sensation, and rarely septal perforation; risk varies with procedure complexity. A detailed preoperative discussion and structured follow‑up are essential for safe care.

Certain conditions make procedures inappropriate or require special precautions. Absolute or relative contraindications include active acute nasal or sinus infection (procedural care is deferred until infection is treated), uncontrolled bleeding disorders or inability to stop anticoagulation without medical clearance, and pregnancy when elective procedures are typically deferred in favor of medical therapy. Specific concerns that alter candidacy include severe mucosal atrophy or prior excessive turbinate resection (increasing empty‑nose risk), recent use of topical sympathomimetic decongestants without planned withdrawal, and significant uncontrolled medical comorbidity that precludes anesthesia. Pediatric patients require age‑appropriate evaluation and may not be candidates for adult techniques without specialist input.

Yes. Posterior nasal nerve procedures require absence of active infection and reasonable mucosal health; severe atrophy may reduce benefit. Turbinate reduction is best when adequate mucosal thickness remains for turbinate‑sparing techniques; prior over‑resection is a contraindication. Septoplasty is deferred until mucosal inflammation is controlled and active infections cleared, and significant coagulopathy must be managed beforehand. Nasal valve repair requires a correctable structural lesion; poor tissue quality or prior complex surgery may limit options and change risk profiles.

If you take anticoagulants or antiplatelet agents, a coordinated plan with your prescribing clinician is required before elective procedures; some medications must be paused safely, and some cannot. Active bleeding disorders often preclude elective nasal procedures until controlled. Pregnancy typically leads to deferral of elective office or operative procedures; medical therapy is favored and definitive planning is delayed until postpartum unless urgent care is required. In all cases, arrange an in‑person risk assessment with your surgeon and your primary medical provider.

Rhinitis medicamentosa results from prolonged topical sympathomimetic decongestant use and presents as rebound congestion. Management begins with stopping the offending nasal spray and initiating topical corticosteroids and nasal care measures. Short courses of oral steroids are rarely used and reserved for selected cases. If congestion persists after reversal, re‑evaluation for structural or neural contributors guides next steps.

Bring a complete medication list, including topical nasal sprays and over‑the‑counter remedies, and records of prior allergy testing or imaging. When safe, avoid topical sympathomimetic decongestant sprays for several days before the visit and discuss antihistamine timing with your clinician. Do not stop prescribed anticoagulation without prior medical clearance. Clear documentation helps the clinician distinguish mucosal from structural contributors during examination.